{"id":"W3169526934","doi":"10.1200/jco.2021.39.15_suppl.9526","title":"Overall survival in patients who received checkpoint inhibitors after completing tebentafusp in a phase 3 randomized trial of first-line metastatic uveal melanoma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Ipilimumab; Interim analysis; Oncology; Nivolumab; Hazard ratio; Pembrolizumab; Progression-free survival; Combination therapy; Refractory (planetary science); Clinical trial; Cancer; Overall survival; Immunotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002794593,0.001076124,0.001928209,0.0003740421,0.0003655147,0.001087471,0.0008166097,0.001233515,0.004444403],"category_scores_gemma":[0.001893056,0.0005193675,0.002405511,0.0004366897,0.0006905767,0.0009317953,0.0004611045,0.003099996,0.0006352185],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001051057,"about_ca_system_score_gemma":0.001317972,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008824327,"about_ca_topic_score_gemma":0.002923186,"domain_scores_codex":[0.9988745,0.0006466853,0.00004701118,0.000173749,0.00006471952,0.000193254],"domain_scores_gemma":[0.9989282,0.000214738,0.0002786777,0.00008899914,0.00004259943,0.0004467182],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9830004,0.002854744,0.003183102,0.0001656343,0.0005753166,0.000047071,0.00002864898,0.0003867043,0.001271091,0.00004979721,0.0008273983,0.007610045],"study_design_scores_gemma":[0.7894551,0.1857055,0.02046835,0.00005192933,0.001216196,0.00009587543,0.00003352327,0.0007927942,0.0006798058,0.0002208958,0.00125736,0.00002266343],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915827,0.003034261,0.0002907474,0.0005598249,0.0002534801,0.001256532,0.001666035,0.00004849276,0.00130798],"genre_scores_gemma":[0.9929878,0.0008942665,0.0003420174,0.0006212124,0.0002552674,0.001362639,0.002054181,0.0000134816,0.001469114],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004444403,"threshold_uncertainty_score":0.01486796,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0808076675845741,"score_gpt":0.4353919557677527,"score_spread":0.3545842881831786,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}